Press release
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
A Deadline is coming up on September 12, 2025 in the lawsuit for certain investors in Biohaven Ltd. (NYSE: BHVN).
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Connecticut the plaintiff alleges on behalf of purchasers of Biohaven Ltd. (NYSE: BHVN) common shares between March 24, 2023 and May 14, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 24, 2023 and May 14, 2025, the Defendants made false and/or misleading statements and/or failed to disclose that troriluzole's regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole's regulatory approval for this indication, were overstated, that BHV-7000's efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated, that all the foregoing, once revealed, was likely to have a significant negative impact on Biohaven's business and financial condition, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.
Those who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025 here
News-ID: 4167119 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Biohaven
Obsessive Compulsive Disorder Market Growth Projections 2024-2034: DelveInsight …
The Key Obsessive Compulsive Disorder Companies in the market include - Biohaven Pharmaceuticals, Inc., AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, and others.
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany,…
Obsessive Compulsive Disorder Market to Show Remarkable Growth Trends from 2024 …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the OCD market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder Market Forecast [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some…
Obsessive Compulsive Disorder Market Expected to Experience Major Growth by 2034 …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the OCD market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder Market Forecast
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some…
Spinocerebellar Ataxias Market Value Strategic Analysis | Biohaven Pharmaceutica …
According to HTF Market Intelligence, the Spinocerebellar Ataxias market to witness a CAGR of xx% during the forecast period (2024-2030). The Latest published a market study on Global Spinocerebellar Ataxias Market provides an overview of the current market dynamics in the Global Spinocerebellar Ataxias space, as well as what our survey respondents- all outsourcing decision-makers- predict the market will look like in 2030. The study breaks the market by revenue…
Investigation announced for Investors in Biohaven Ltd. (NYSE: BHVN) over potenti …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Biohaven Ltd. directors breached their fiduciary duties and caused damage to the company and its shareholders.
New Haven, CT based…
Obsessive Compulsive Disorder Market to Exhibit Rapid Growth Rate During the For …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Obsessive Compulsive Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder…
